1. Home
  2. VEEA vs UPB Comparison

VEEA vs UPB Comparison

Compare VEEA & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VEEA
  • UPB
  • Stock Information
  • Founded
  • VEEA 2014
  • UPB 2021
  • Country
  • VEEA United States
  • UPB United States
  • Employees
  • VEEA N/A
  • UPB N/A
  • Industry
  • VEEA
  • UPB
  • Sector
  • VEEA
  • UPB
  • Exchange
  • VEEA NYSE
  • UPB NYSE
  • Market Cap
  • VEEA 83.9M
  • UPB 521.3M
  • IPO Year
  • VEEA N/A
  • UPB 2024
  • Fundamental
  • Price
  • VEEA $1.68
  • UPB $11.49
  • Analyst Decision
  • VEEA
  • UPB Strong Buy
  • Analyst Count
  • VEEA 0
  • UPB 4
  • Target Price
  • VEEA N/A
  • UPB $56.50
  • AVG Volume (30 Days)
  • VEEA 29.6K
  • UPB 496.2K
  • Earning Date
  • VEEA 08-23-2025
  • UPB 08-14-2025
  • Dividend Yield
  • VEEA N/A
  • UPB N/A
  • EPS Growth
  • VEEA N/A
  • UPB N/A
  • EPS
  • VEEA N/A
  • UPB N/A
  • Revenue
  • VEEA $139,252.00
  • UPB $2,296,000.00
  • Revenue This Year
  • VEEA N/A
  • UPB N/A
  • Revenue Next Year
  • VEEA N/A
  • UPB N/A
  • P/E Ratio
  • VEEA N/A
  • UPB N/A
  • Revenue Growth
  • VEEA N/A
  • UPB N/A
  • 52 Week Low
  • VEEA $1.33
  • UPB $5.14
  • 52 Week High
  • VEEA $18.56
  • UPB $29.46
  • Technical
  • Relative Strength Index (RSI)
  • VEEA N/A
  • UPB N/A
  • Support Level
  • VEEA N/A
  • UPB N/A
  • Resistance Level
  • VEEA N/A
  • UPB N/A
  • Average True Range (ATR)
  • VEEA 0.00
  • UPB 0.00
  • MACD
  • VEEA 0.00
  • UPB 0.00
  • Stochastic Oscillator
  • VEEA 0.00
  • UPB 0.00

About VEEA VEEA INC

Veea Inc is a company providing an edge platform having extensive knowledge and expertise on content delivery and edge computing, and has brought a broad range of Wi-Fi, 4G/5G mobile wireless, and IoT products to market over the past two decades. The company has first-in-class VeeaHub smart connectivity and computing hubs that integrate a full range of connectivity options, application processing power, and a full security stack to form an elastic edge computing platform with a dynamic connectivity and application mesh that can easily be deployed and centrally managed from the cloud.

About UPB UPSTREAM BIO INC

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.

Share on Social Networks: